Scholar Rock Holding Corporation Common Stock, also called Scholar Rock, is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. Read More The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA. The listed name for SRRK is Scholar Rock Holding Corporation Common Stock.